Cytovale

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s FDA-cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells (WBCs) to stratify a patient’s risk of sepsis from a standard blood draw in ~8 minutes. The IntelliSep test categorizes patients into three bands according to their probability of sepsis.
The results may equip providers with a tool to optimize clinical outcomes and empower hospitals to improve resource utilization and achieve operational excellence.

Made up of an extraordinary team of life scientists, engineers, clinicians, and dreamers, Cytovale intends to accelerate the time it takes to get from triage to life-saving therapies. For more information, please visit our website: www.cytovale.com